Completed PHASE1 INTERVENTIONAL 1-arm NCT03418896

Extragonadal Effects of hCG on Calcium Homeostasis

Novel Extragonadal Effects of Human Chorion Gonadotropin (hCG) on Calcium Homeostasis

Sponsor: Martin Blomberg Jensen

Conditions Calcium Disorder Hypogonadism Renal Disease

Interventions human chorionic gonadotropin

Updated 10 times since 2018 Last updated: Jun 11, 2023 Started: Jan 6, 2018 Primary completion: Oct 31, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Calcium Disorder and Hypogonadism and is currently completed. Martin Blomberg Jensen leads this study, which shows 10 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jul 2023 — Jul 2024 [monthly]

Completed PHASE1

Status: Unknown Status → Completed · Phase: NA → PHASE1
Feb 2023 — Jul 2023 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Feb 2021 — Feb 2023 [monthly]

Active Not Recruiting NA

▶ Show 5 earlier versions

Jan 2021 — Feb 2021 [monthly]

Active Not Recruiting NA
Mar 2020 — Jan 2021 [monthly]

Active Not Recruiting NA
Apr 2019 — Mar 2020 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jun 2018 — Apr 2019 [monthly]

Recruiting NA
Mar 2018 — Jun 2018 [monthly]

Recruiting NA

First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Martin Blomberg Jensen

Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark